NCT03564093View on ClinicalTrials.gov

Intranasal Dexmedetomidine Sedation and Analgesia During Pediatric Emergency Room Procedures

PHASE4RecruitingINTERVENTIONAL
Enrollment

112

Participants

Timeline

Start Date

March 15, 2018

Primary Completion Date

March 14, 2025

Study Completion Date

June 10, 2025

Conditions
PainAnesthesia
Interventions
DRUG

Intranasal Drug

1µg/kg of dexmedetomidine is given 30 minutes prior to intravenous cannulation or lumbar puncture

DRUG

Intranasal Drug

Intranasal 4,5% saline is given as a placebo 30 minutes prior to intravenous cannulation or lumbar puncture

Trial Locations (1)

Unknown

RECRUITING

Oulu University Hospital, Oulu

All Listed Sponsors
lead

University of Oulu

OTHER